Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Flynn

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of the Association of Nurses in AIDS Care : JANAC|August 18, 2015
Provider perspectives regarding the health care needs of a key population: HIV-infected prisoners after incarcerationTurquoise Sidibe, Carol Golin, Kea Turner, et al.
Journal of Pediatric Orthopedics|September 20, 2011
The findings of preoperative cardiac screening studies in adolescent idiopathic scoliosisLisa Ipp, Patrick Flynn, John Blanco, et al.
Artificial Intelligence in Medicine|May 9, 2024
Identifying pediatric heart murmurs and distinguishing innocent from pathologic using deep learningGeorge Zhou, Candace Chien, Justin Chen, et al.
International Journal of Immunogenetics|August 22, 2022
An early evaluation of the HISTO SPOT<sup>®</sup> AB ID Class I & II test in cardiothoracic transplant patientsJames Cashin, Patrick Flynn, Judith Worthington, et al.
Lancet (London, England)|May 31, 2011
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trialRoy S Herbst, Rafat Ansari, Frederique Bustin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trialPatrick J Loehrer, Yang Feng, Higinia Cardenes, et al.
Clinical Breast Cancer|March 27, 2012
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trialWinston W Tan, Jacob B Allred, Muhammad Salim, et al.
BMC Infectious Diseases|October 31, 2019
Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populationsWilliam E Cunningham, Robin M Nance, Carol E Golin, et al.
Cancer Investigation|June 17, 2006
A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancerJulian R Molina, Daniel Nikcevich, Shauna Hillman, et al.
Oncotarget|February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer studyNilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of the Association of Nurses in AIDS Care : JANAC|August 18, 2015
Provider perspectives regarding the health care needs of a key population: HIV-infected prisoners after incarcerationTurquoise Sidibe, Carol Golin, Kea Turner, et al.
Journal of Pediatric Orthopedics|September 20, 2011
The findings of preoperative cardiac screening studies in adolescent idiopathic scoliosisLisa Ipp, Patrick Flynn, John Blanco, et al.
Artificial Intelligence in Medicine|May 9, 2024
Identifying pediatric heart murmurs and distinguishing innocent from pathologic using deep learningGeorge Zhou, Candace Chien, Justin Chen, et al.
International Journal of Immunogenetics|August 22, 2022
An early evaluation of the HISTO SPOT<sup>®</sup> AB ID Class I & II test in cardiothoracic transplant patientsJames Cashin, Patrick Flynn, Judith Worthington, et al.
Lancet (London, England)|May 31, 2011
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trialRoy S Herbst, Rafat Ansari, Frederique Bustin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trialPatrick J Loehrer, Yang Feng, Higinia Cardenes, et al.
Clinical Breast Cancer|March 27, 2012
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trialWinston W Tan, Jacob B Allred, Muhammad Salim, et al.
BMC Infectious Diseases|October 31, 2019
Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populationsWilliam E Cunningham, Robin M Nance, Carol E Golin, et al.
Cancer Investigation|June 17, 2006
A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancerJulian R Molina, Daniel Nikcevich, Shauna Hillman, et al.
Oncotarget|February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer studyNilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Pageof 4